Agilent Technologies (A) Profit Margin (2008 - 2026)
Agilent Technologies (A) profit margin from Jul 31, 2008 to Jan 31, 2026. The current Agilent Technologies (A) profit margin is 16.96%. You can export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Annual Profit Margin
Quarterly Profit Margin
Annual Profit Margin change of Agilent Technologies (A)
| Year | Profit Margin | Change |
|---|---|---|
| 2025 | 18.75% | -5.29% |
| 2024 | 19.80% | +9.11% |
| 2023 | 18.15% | -0.90% |
| 2022 | 18.31% | -4.37% |
| 2021 | 19.15% | +42.19% |
| 2020 | 13.47% | -35.08% |
| 2019 | 20.74% | +222.58% |
| 2018 | 6.43% | -57.96% |
| 2017 | 15.30% | +39.11% |
| 2016 | 10.99% | +10.72% |
| 2015 | 9.93% | -26.78% |
| 2014 | 13.56% | -28.05% |
| 2013 | 18.85% | +12.12% |
| 2012 | 16.81% | +9.90% |
| 2011 | 15.30% | +21.76% |
| 2010 | 12.56% | -1916.15% |
| 2009 | -0.69% | -105.76% |
| 2008 | 12.00% | +1.96% |
| 2007 | 11.77% | N/A |
Comparison Agilent Technologies (A) profit margin with competitors
Agilent Technologies (A) profit margin is 16.96%.
| Ticker | Name | Profit Margin | Upside |
|---|---|---|---|
| IDXX | Idexx Laboratories Inc | 24.41% | +43.90% |
| VCYT | Veracyte Inc | 20.64% | +21.67% |
| QGEN | Qiagen NV | 20.33% | +19.85% |
| MTD | Mettler-Toledo International Inc | 17.89% | +5.46% |
| MEDP | Medpace Holdings Inc | 17.53% | +3.34% |
| DHR | Danaher Corp | 17.29% | +1.93% |
| BLLN | Billiontoone Inc - Class A | 16.58% | -2.26% |
| TMO | Thermo Fisher Scientific Inc | 15.00% | -11.57% |
| ILMN | Illumina Inc | 12.28% | -27.61% |
| SHC | Sotera Health Company | 9.49% | -44.06% |
| DGX | Quest Diagnostics Inc | 8.70% | -48.71% |
| LH | Laboratory Corp Of America Holdings | 7.85% | -53.72% |
| IQV | IQVIA Holdings Inc | 6.60% | -61.09% |
| FONR | Fonar Corp | 6.20% | -63.45% |
| RVTY | Revvity Inc | 5.73% | -66.22% |
| ICLR | Icon Plc | 2.78% | -83.61% |
| CDNA | Caredx Inc | 2.39% | -85.91% |